Literature DB >> 19724856

Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.

Jie Yao1, Tao Zhang, Jinghua Ren, Minxia Yu, Gang Wu.   

Abstract

The stem cell marker CD133/prominin-1, is a pentaspan membrane glycoprotein, which has also been identified as a cancer stem cell (CSC) marker in several solid tumor types, including those of the prostate, liver, colon and brain. The function of CD133 in these tumors is still unknown. We hypothesize that the function of CD133 is correlated with the characteristics of the CD133+ CSCs and may affect the growth of the tumor cell population as a whole. In this study we used antisense oligodeoxynucleotides (ASODNs) of CD133 to knock-down (KD) CD133 expression. We showed that the CD133-KD inhibited proliferation of U251 human glioma cells, decreased the colony forming ability and altered the cell cycle distribution in Huh-7 human hepatocellular carcinoma cells. Our data suggest that CD133 may play an important functional role in the growth of these tumor cells. Moreover, this study also showed that prominin-2, another protein in the same family as CD133/prominin-1, may not have a similar function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724856     DOI: 10.3892/or_00000500

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

2.  Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.

Authors:  Lige Qiu; Hailiang Li; Sirui Fu; Xiaofang Chen; Ligong Lu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

Review 3.  Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Anticancer Agents Med Chem       Date:  2010-02       Impact factor: 2.505

Review 4.  Glioma stem cell maintenance: the role of the microenvironment.

Authors:  John M Heddleston; Masahiro Hitomi; Monica Venere; William A Flavahan; Kenneth Yang; Youngmi Kim; Sana Minhas; Jeremy N Rich; Anita B Hjelmeland
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 5.  Ovarian cancer stem cell markers: prognostic and therapeutic implications.

Authors:  Daniela Burgos-Ojeda; Bo R Rueda; Ronald J Buckanovich
Journal:  Cancer Lett       Date:  2012-02-11       Impact factor: 8.679

6.  Matrix Hyaluronic Acid and Hypoxia Influence a CD133+ Subset of Patient-Derived Glioblastoma Cells.

Authors:  Jee-Wei Emily Chen; Sarah Leary; Victoria Barnhouse; Jann N Sarkaria; Brendan A C Harley
Journal:  Tissue Eng Part A       Date:  2021-12-27       Impact factor: 4.080

Review 7.  Research progress and prospects of markers for liver cancer stem cells.

Authors:  Cheng-Pei Zhu; An-Qiang Wang; Hao-Hai Zhang; Xue-Shuai Wan; Xiao-Bo Yang; Shu-Guang Chen; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 8.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

9.  Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway.

Authors:  Yi Chen; Wenwei Sun; Ran He; Feiyan Zhang; Hongyu Wang; Panhong Li; Rong-Guang Shao; Xiaoyu Xu
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

10.  Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells.

Authors:  Ran Wang; Shuxun Chen; Changxian Li; Kevin Tak Pan Ng; Chi-wing Kong; Jinping Cheng; Shuk Han Cheng; Ronald A Li; Chung Mau Lo; Kwan Man; Dong Sun
Journal:  BMC Cancer       Date:  2016-02-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.